Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, today announced that the independent Safety Monitoring Board (SMB) for its Phase 2 trial of GKT831 for the treatment of Primary Biliary Cholangitis (PBC) held its first pre-planned data review meeting and recommended the continuation of the Company’s trial without protocol amendment. In addition, and as previously indicated, no serious adverse events, liver-related adverse events or drop outs have been reported to date.
Kuros Biosciences receives European clearance for MagnetOs Putty and prepares for commercial roll-out in the U.S. and Europe
Kuros Biosciences (SIX: KURN) announced today that it has received the CE Mark for MagnetOs Putty indicated for use as an osteoconductive and osteoinductive bone
void filler in the skeletal system (i.e. spine, extremities, pelvis, cranium, mandible and maxilla). This market clearance allows commercialization of MagnetOs Putty in Europe, and complements the existing clearance for MagnetOs Granules, and the 510K clearance for both formulations from the U.S. Food and Drug Administration as an autograft extender in the posterolateral spine. With its unique submicron surface
topography, MagnetOs preferentially directs early wound healing toward the bone-forming pathway. Numerous studies have shown that MagnetOs leads to progressive bone formation and implant resorption comparable to autograft (patient’s own bone), the current gold standard.
Nexthink®, a leader in digital employee experience management software for enterprises, and BRACHIN LLC, a leading IT enterprise software and consulting firm, announced a partnership to help satisfy a forecasted increase in demand for improved digital experience in the workplace. As employee digital experience becomes a top priority for CIOs, the demand for solutions and experts that can ensure that organizations have the highest-quality digital experience becomes a necessity.
JenaValve Technology Continues CE Mark Study Treating Severe Aortic Stenosis with Next-Generation System; Patient Enrollment and Successful Implantations with the Everdur™ Pericardial Aortic Valve and Coronatix™ Delivery Catheter
JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced successful patient enrollment in the CE Mark study of the next generation JenaValve Pericardial TAVR System utilizing the CoronatixTM Transfemoral Delivery Catheter for the percutaneous treatment of severe aortic stenosis. The JenaValve Pericardial TAVR System is an investigational device in the United States and internationally.
JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member.
The Church of England (www.churchofengland.org) is making contactless, virtual terminal, and SMS mobile payments available to over 16,000 churches, cathedrals, and religious sites throughout England, in a bid to make donations and transactions faster and easier for the Church’s congregations.
Kuros Biosciences AG (SIX: KURN) announced today that its Dutch subsidiary, Kuros Biosciences BV, has been granted the European patent, EP3021878, entitled “Method for producing an osteoinductive calcium phosphate and products thus obtained” by
the European Patent Office (EPO).
Sennheiser is aiming to strengthen its position as a leading provider of immersive audio solutions with an investment in Dear Reality, experts in spatial audio algorithms and audio VR/AR software, and the acquisition of technologies from Sonic Emotion, a developer of 3D audio software and processing solutions. Both companies have developed unique expertise and tools for the creation and rendering of immersive audio in object-based and scene-based formats.
Nexthink®, a leader in digital experience management software for enterprises, today highlighted a successful 2017, announcing that it achieved a 74 percent increase in annual subscription revenue growth. This success was driven by a growing market for solutions that help enterprises to ensure a high-quality digital experience for their employees.